Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smith, M. L.
Right arrow Articles by Seo, Y. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, M. L.
Right arrow Articles by Seo, Y. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis, Vol. 17, No. 2, 149-156, March 2002
© 2002 UK Environmental Mutagen Society/Oxford University Press


REVIEW

p53 regulation of DNA excision repair pathways

Martin L. Smith,1 and Young R. Seo

Indiana University Cancer Center, Department of Microbiology, Walther Oncology Center, Indiana University School of Medicine, and Walther Cancer Institute, Indianapolis, IN 46202, USA

The regulation of DNA excision repair pathways by p53 and its downstream genes is an emerging body of literature, largely distinct and separable from the more-studied cell cycle arrest and apoptosis responses regulated by p53. Regulation of nucleotide excision repair of UV-damage by p53 and its downstream genes Gadd45 and p48XPE has been well-documented, but much remains to be done in elucidating mechanisms. Moreover, p53 also participates in base excision repair of hydrogen peroxide-induced damage, still at an early stage of investigation. In human cancers carrying inactivating mutations in p53, especially those wherein p53 mutation occurs early, accelerated mutagenesis by exogenous and endogenous DNA damage is predicted. At the same time, the excision repair pathways could provide a useful target for DNA-damaging chemotherapeutics against p53-defective cancers, having decreased ability to repair chemotherapeutic damage. To our knowledge, this is the first review to address this emerging field.

1 To whom correspondence should be addressed at: Indiana University Cancer Center, 1044 West Walnut, R155, Indianapolis, IN 46202, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. J. Hughes, G. P. Meares, K. T. Chambers, and J. A. Corbett
Repair of Nitric Oxide-damaged DNA in {beta}-Cells Requires JNK-dependent GADD45{alpha} Expression
J. Biol. Chem., October 2, 2009; 284(40): 27402 - 27408.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. M. K. Pulukuri, J. A. Knost, N. Estes, and J. S. Rao
Small Interfering RNA-Directed Knockdown of Uracil DNA Glycosylase Induces Apoptosis and Sensitizes Human Prostate Cancer Cells to Genotoxic Stress
Mol. Cancer Res., August 1, 2009; 7(8): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. R. Cuddihy, F. Jalali, C. Coackley, and R. G. Bristow
WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells
Mol. Cancer Ther., April 1, 2008; 7(4): 980 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. L. Busceti, F. Biagioni, B. Riozzi, G. Battaglia, M. Storto, C. Cinque, G. Molinaro, R. Gradini, A. Caricasole, A. M. Canudas, et al.
Enhanced Tau Phosphorylation in the Hippocampus of Mice Treated with 3,4-Methylenedioxymethamphetamine ("Ecstasy")
J. Neurosci., March 19, 2008; 28(12): 3234 - 3245.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Dunn, M. Potter, A. Rees, and T. M. Runger
Activation of the Fanconi Anemia/BRCA Pathway and Recombination Repair in the Cellular Response to Solar Ultraviolet Light
Cancer Res., December 1, 2006; 66(23): 11140 - 11147.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Yoshioka, A Boivin, P Ye, F Labrie, and J St-Amand
Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression.
J. Mol. Endocrinol., April 1, 2006; 36(2): 247 - 259.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Hakansson, A. Hofer, and L. Thelander
Regulation of Mammalian Ribonucleotide Reduction and dNTP Pools after DNA Damage and in Resting Cells
J. Biol. Chem., March 24, 2006; 281(12): 7834 - 7841.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Sarkar-Agrawal, I. Vergilis, N. E. Sharpless, R. A. DePinho, and T. M. Runger
Impaired Processing of DNA Photoproducts and Ultraviolet Hypermutability With Loss of p16INK4a or p19ARF
J Natl Cancer Inst, December 1, 2004; 96(23): 1790 - 1793.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. R. Trzeciak, S. G. Nyaga, P. Jaruga, A. Lohani, M. Dizdaroglu, and M. K. Evans
Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145
Carcinogenesis, August 1, 2004; 25(8): 1359 - 1370.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Raffoul, D. C. Cabelof, J. Nakamura, L. B. Meira, E. C. Friedberg, and A. R. Heydari
Apurinic/Apyrimidinic Endonuclease (APE/REF-1) Haploinsufficient Mice Display Tissue-specific Differences in DNA Polymerase {beta}-Dependent Base Excision Repair
J. Biol. Chem., April 30, 2004; 279(18): 18425 - 18433.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. E. Reczek, E. R. Flores, A. S. Tsay, L. D. Attardi, and T. Jacks
Multiple Response Elements and Differential p53 Binding Control Perp Expression During Apoptosis
Mol. Cancer Res., December 1, 2003; 1(14): 1048 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. K. Sah, A. Munshi, T. Nishikawa, T. Mukhopadhyay, J. A. Roth, and R. E. Meyn
Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity
Mol. Cancer Ther., November 1, 2003; 2(11): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhou, X. Liu, X. Mo, L. Xue, D. Darwish, W. Qiu, J. Shih, E. B. Hwu, F. Luh, and Y. Yen
The Human Ribonucleotide Reductase Subunit hRRM2 Complements p53R2 in Response to UV-Induced DNA Repair in Cells with Mutant p53
Cancer Res., October 15, 2003; 63(20): 6583 - 6594.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Xue, B. Zhou, X. Liu, W. Qiu, Z. Jin, and Y. Yen
Wild-Type p53 Regulates Human Ribonucleotide Reductase by Protein-Protein Interaction with p53R2 as well as hRRM2 Subunits
Cancer Res., March 1, 2003; 63(5): 980 - 986.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. R. Seo, M. R. Kelley, and M. L. Smith
From the Cover: Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
PNAS, October 29, 2002; 99(22): 14548 - 14553.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.